Sort   by:  
 Page size 
UnknownThe Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers.
Not available
S-EPMC7929225 | biostudies-literature
UnknownCasirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904 | biostudies-literature
UnknownRisk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci.
Not available
S-EPMC4491026 | biostudies-literature
UnknownAn Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status.
Not available
S-EPMC8994591 | biostudies-literature
UnknownAntibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.
Not available
S-EPMC7781098 | biostudies-literature
UnknownThe National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment.
Not available
S-EPMC7454687 | biostudies-literature
UnknownPrehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial.
Not available
S-EPMC6497986 | biostudies-literature
UnknownPathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
Not available
S-EPMC7864894 | biostudies-literature
UnknownSARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.
Not available
S-EPMC8723827 | biostudies-literature
UnknownGlobal Retinoblastoma Presentation and Analysis by National Income Level.
Not available
S-EPMC7047856 | biostudies-literature
Sort   by:  
 Page size